Barr Launches Plan B(R) OTC/Rx Dual-Label Product; Awarded 3 Years New Product Exclusivity (PR Newswire via Yahoo! Finance)
Barr Pharmaceuticals, Inc. today announced that its Duramed Pharmaceuticals, Inc. subsidiary has initiated shipment of the dual-label Plan B emergency contraceptive OTC/Rx product to customers and that the product will be available in pharmacies across the United States by mid-November.

IPS and Smart Consulting Announce Formation of Smart Bio Pharma (Business Wire via Yahoo! Finance)
LAFAYETTE HILL, Pa. & WEST CHESTER, Pa.----Integrated Project Services , a leading, full-service engineering, design/build, validation, and compliance company dedicated to assisting pharmaceutical and biotech companies improve operations, and Smart Consulting Group, LLC, providing technical and regulatory assistance for a range of pharmaceuticals, biologics, and novel combination products, today

Talecris Biotherapeutics to Acquire Plasma Collection Centers (Business Wire via Yahoo! Finance)
RESEARCH TRIANGLE PARK, N.C.----Talecris Plasma Resources, a wholly owned subsidiary of Talecris Biotherapeutics, Inc. , today announced it has signed a purchase acquisition agreement with International BioResources, LLC to acquire the majority of IBR's plasma sourcing centers that are geographically distributed across 21 states in the U.S., employing nearly 1,000 people.